IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avalo Therapeutics Inc

CUSIP: 05338F207 | 52 institutional holders

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Parallel Advisors, LLC0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Parallel Advisors, LLC
0$00.0%IndexLowSan Francisco, CA2024-02-12